Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Down's syndrome.

Nancy J Roizen1, David Patterson

  • 1Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY 13210, USA. roizenn@upstate.edu <roizenn@upstate.edu>

Lancet (London, England)
|April 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalamic sonication in chronic disorders of consciousness: a mechanistic single-arm clinical trial.

medRxiv : the preprint server for health sciences·2026
Same author

Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine.

Brain sciences·2025
Same author

Rotationally Resolved Spectroscopy of a Single Polyatomic Molecule.

Physical review letters·2025
Same author

The influence of crop type on pesticide wash-off parameters for use in environmental fate modelling.

Pest management science·2024
Same author

Collective action and legal mobilisation for the right to health in the climate crisis.

Lancet (London, England)·2024
Same author

Ecotoxicological soil risk assessment under the new soil exposure framework - an impact assessment.

Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes·2024
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Advances in understanding Down's syndrome (DS) involve genetic insights and improved medical care. Research focuses on prenatal screening, co-occurring conditions, and enhancing the quality of life for individuals with DS.

Area of Science:

  • Genetics and Genomics
  • Developmental Biology
  • Medical Research

Background:

  • Chromosome 21 sequencing and mouse models offer insights into Down's syndrome neuropathogenesis and phenotype.
  • Prenatal screening research aims to improve detection methods and reduce invasive procedures like amniocentesis.

Purpose of the Study:

  • To summarize current research and clinical interests in Down's syndrome.
  • To highlight advancements in understanding the syndrome's genetic basis, associated conditions, and management.
  • To discuss improvements in the quality of life for individuals with Down's syndrome.

Main Methods:

  • Genetic sequencing of chromosome 21.
  • Development and utilization of mouse models for Down's syndrome.
  • Review of current research in prenatal diagnosis, associated diseases, and clinical management.

Related Experiment Videos

Main Results:

  • Established links between genes on chromosome 21 and Down's syndrome neuropathogenesis.
  • Identified associations with coeliac disease and Alzheimer's disease, alongside improved life expectancy.
  • Demonstrated benefits of comprehensive medical care, psychiatric disorder treatment, and early educational interventions.

Conclusions:

  • Continued research is crucial for understanding Down's syndrome genetics and phenotype.
  • Integrated medical and educational approaches significantly improve the quality of life for individuals with Down's syndrome.
  • Global disparities in approaches and outcomes necessitate further investigation and equitable care strategies.